Profound Medical Corp.
PROF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $186 | $180 | $227 | $230 |
| - Cash | $55 | $26 | $47 | $67 |
| + Debt | $5 | $8 | $8 | $1 |
| Enterprise Value | $136 | $161 | $189 | $164 |
| Revenue | $10 | $7 | $7 | $7 |
| % Growth | 41.2% | 7.8% | -2.8% | – |
| Gross Profit | $7 | $4 | $3 | $3 |
| % Margin | 65.9% | 60.9% | 45.2% | 43% |
| EBITDA | -$26 | -$27 | -$27 | -$29 |
| % Margin | -251.7% | -372% | -398.2% | -416.8% |
| Net Income | -$26 | -$29 | -$29 | -$31 |
| % Margin | -260.4% | -396.8% | -429.1% | -446.7% |
| EPS Diluted | -1.07 | -1.35 | -1.38 | -1.5 |
| % Growth | 20.7% | 2.2% | 8% | – |
| Operating Cash Flow | -$23 | -$23 | -$26 | -$22 |
| Capital Expenditures | $0 | $0 | $0 | -$1 |
| Free Cash Flow | -$23 | -$23 | -$26 | -$23 |